Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2011, Article ID 970245, 6 pages
http://dx.doi.org/10.4061/2011/970245
Review Article

Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control

Division of Nephrology, Klinikum Coburg, 96450 Coburg, Germany

Received 21 December 2010; Accepted 14 March 2011

Academic Editor: Domenico Russo

Copyright © 2011 Markus Ketteler. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Isakova, O. Gutierrez, A. Shah et al., “Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD,” Journal of the American Society of Nephrology, vol. 19, no. 3, pp. 615–623, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Portale, B. P. Halloran, and R. C. Morris, “Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D,” The Journal of Clinical Investigation, vol. 80, no. 4, pp. 1147–1154, 1987. View at Google Scholar · View at Scopus
  3. T. Berndt and R. Kumar, “Novel mechanisms in the regulation of phosphorus homeostasis,” Physiology, vol. 24, no. 1, pp. 17–25, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Nishida, Y. Taketani, H. Yamanaka-Okumura et al., “Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men,” Kidney International, vol. 70, no. 12, pp. 2141–2147, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Kestenbaum, J. N. Sampson, K. D. Rudser et al., “Serum phosphate levels and mortality risk among people with chronic kidney disease,” Journal of the American Society of Nephrology, vol. 16, no. 2, pp. 520–528, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Y. Hsu and G. M. Chertow, “Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency,” Nephrology Dialysis Transplantation, vol. 17, no. 8, pp. 1419–1425, 2002. View at Google Scholar · View at Scopus
  7. A. Levin, G. L. Bakris, M. Molitch et al., “Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease,” Kidney International, vol. 71, no. 1, pp. 31–38, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. O. Gutierrez, T. Isakova, E. Rhee et al., “Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease,” Journal of the American Society of Nephrology, vol. 16, no. 7, pp. 2205–2215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Liu and L. D. Quarles, “How fibroblast growth factor 23 works,” Journal of the American Society of Nephrology, vol. 18, no. 6, pp. 1637–1647, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Prié, P. U. Torres, and G. Friedlander, “Latest findings in phosphate homeostasis,” Kidney International, vol. 75, no. 9, pp. 882–889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Wolf, “Forging forward with 10 burning questions on FGF23 in kidney disease,” Journal of the American Society of Nephrology, vol. 21, no. 9, pp. 1427–1435, 2010. View at Publisher · View at Google Scholar
  12. J. Silver and T. Naveh-Many, “Phosphate and the parathyroid,” Kidney International, vol. 75, no. 9, pp. 898–905, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Noori, K. Kalantar-Zadeh, C. P. Kovesdy, R. Bross, D. Benner, and J. D. Kopple, “Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 4, pp. 683–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. K. E. Lynch, R. Lynch, G. C. Curhan, and S. M. Brunelli, “Prescribed dietary phosphate restriction and survival among hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 3, pp. 620–629, 2011. View at Publisher · View at Google Scholar
  15. K. Zeller, E. Whittaker, L. Sullivan, P. Raskin, and H. R. Jacobson, “Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 324, no. 2, pp. 78–84, 1991. View at Google Scholar · View at Scopus
  16. M. H. Lafage-Proust, C. Combe, N. Barthe, and M. Aparicio, “Bone mass and dynamic parathyroid function according to bone histology in nondialyzed uremic patients after long-term protein and phosphorus restriction,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 2, pp. 512–519, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Sullivan, S. S. Sayre, J. B. Leon et al., “Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial,” JAMA, vol. 301, no. 6, pp. 629–635, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Uribarri, “Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake,” Seminars in Dialysis, vol. 20, no. 4, pp. 295–301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Kalantar-Zadeh, L. Gutekunst, R. Mehrotra et al., “Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 3, pp. 519–530, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. L. H. Kayne, D. Z. D'Argenio, J. H. Meyer, M. S, Hu, N. Jamgotchian, and D. B. N. Lee, “Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach,” The Journal of Clinical Investigation, vol. 91, no. 3, pp. 915–922, 1993. View at Google Scholar · View at Scopus
  21. L. Bohn, A. S. Meyer, and S. K. Rasmussen, “Phytate: impact on environment and human nutrition. A challenge for molecular breeding,” Journal of Zhejiang University: Science B, vol. 9, no. 3, pp. 165–191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. X. G. Lei and J. M. Porres, “Phytase enzymology, applications, and biotechnology,” Biotechnology Letters, vol. 25, no. 21, pp. 1787–1794, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. O. M. Gutiérrez, C. Anderson, T. Isakova et al., “Low socioeconomic status associates with higher serum phosphate irrespective of race,” Journal of the American Society of Nephrology, vol. 21, no. 11, pp. 1953–1960, 2010. View at Publisher · View at Google Scholar
  24. “Kidney disease: improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD),” Kidney International. Supplement, no. 113, pp. S1–S130, 2009.
  25. G. A. Block, D. M. Spiegel, J. Ehrlich et al., “Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis,” Kidney International, vol. 68, no. 4, pp. 1815–1824, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. W. G. Goodman, J. Goldin, B. D. Kuizon et al., “Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis,” The New England Journal of Medicine, vol. 342, no. 20, pp. 1478–1483, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ketteler, M. Rix, S. Fan et al., “Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 4, pp. 1125–1130, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. S. M. Sprague, H. Abboud, P. Qiu, M. Dauphin, P. Zhang, and W. Finn, “Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial,” Clinical Journal of the American Society of Nephrology, vol. 4, no. 1, pp. 178–185, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Russo, I. Miranda, C. Ruocco et al., “The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer,” Kidney International, vol. 72, no. 10, pp. 1255–1261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Nagano, S. Miyata, M. Abe et al., “Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats,” Kidney International, vol. 69, no. 3, pp. 531–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Isakova, O. M. Gutirrez, K. Smith et al., “Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease,” Nephrology Dialysis Transplantation, vol. 26, no. 2, pp. 584–591, 2011. View at Publisher · View at Google Scholar
  32. G. A. Block, M. S. Persky, M. Ketteler et al., “A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology,” Hemodialysis International, vol. 13, no. 3, pp. 360–362, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. B. Wetmore and L. D. Quarles, “Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?” Nature Clinical Practice Nephrology, vol. 5, no. 1, pp. 24–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Evenepoel, B. Meijers, L. Viaene et al., “Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 7, pp. 1268–1276, 2010. View at Publisher · View at Google Scholar